Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Short-term Investments: 2009-2012

Historic Short-term Investments for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $186.1 million.

  • Lexicon Pharmaceuticals' Short-term Investments rose 63.76% to $186.1 million in Q3 2012 from the same period last year, while for Sep 2012 it was $186.1 million, marking a year-over-year increase of 63.76%. This contributed to the annual value of $95.4 million for FY2011, which is 41.81% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Short-term Investments stood at $186.1 million for Q3 2012, which was down 5.89% from $197.7 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' Short-term Investments' 5-year high stood at $224.6 million during Q1 2012, with a 5-year trough of -$60.0 million in Q1 2009.
  • Its 3-year average for Short-term Investments is $126.5 million, with a median of $144.5 million in 2011.
  • In the last 5 years, Lexicon Pharmaceuticals' Short-term Investments plummeted by 66.45% in 2010 and then skyrocketed by 499.95% in 2011.
  • Over the past 4 years, Lexicon Pharmaceuticals' Short-term Investments (Quarterly) stood at $56.5 million in 2009, then surged by 189.88% to $163.9 million in 2010, then plummeted by 41.81% to $95.4 million in 2011, then surged by 63.76% to $186.1 million in 2012.
  • Its last three reported values are $186.1 million in Q3 2012, $197.7 million for Q2 2012, and $224.6 million during Q1 2012.